Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

Presentation TCT 2017

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

Presenter: Manel Sabate, Ashok Seth, Patrick W. Serruys

November 01, 2017

Presentation TCT 2017

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

Presenter: Patrick W. Serruys, Liansheng Wang, MD

November 01, 2017

Presentation TCT 2017

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Presenter: Patrick W. Serruys, Konstantinos Voudris

November 01, 2017

Presentation TCT 2017

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Presenter: Patrick W. Serruys, Ori Ben-Yehuda

November 01, 2017

Presentation TCT 2017

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Cosmo Godino, MD

November 01, 2017

Presentation TCT 2017

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Presenter: Steven R. Bailey, Patrick W. Serruys, Tobias Schmidt, MD

November 01, 2017

Presentation TCT 2017

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Presenter: Steven R. Bailey, Patrick W. Serruys, Angelo Biviano, MD

November 01, 2017

Presentation TCT 2017

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based Arteriosorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

Presenter: Jeffrey J. Popma, John G. Webb, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

Presenter: Fernando Alfonso, Patrick W. Serruys, Hemal Gada

October 30, 2017

Presentation TCT 2017

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

Presenter: Fernando Alfonso, Patrick W. Serruys, Paul Kurlansky

October 30, 2017

Presentation TCT 2017

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Presenter: Fernando Alfonso, Patrick W. Serruys, Adrian P. Banning

October 30, 2017

Advertisement

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

The Thin-Strut PLLA-Based Arteriosorb

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Live From Denver: TCT 2017, Day Two

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content